Front Page  |  China  |  India  |  Japan  |  Korea  |  Other Asia News  |  Other Emerging Markets  |  Features

---

With Leadership Changes On The Horizon, Chinese Vice Premier Sheds Light On Future Of China Healthcare Reform / Analysts predict that healthcare reforms will continue and that major policy changes are unlikely during the leadership transition, which starts next year. / PharmAsia News Dec. 2, 2011 5:30 PM GMT

A Big Hit But A Small Miss? Lipitor Generic Launched But Ranbaxy’s Caduet Prospects In Doubt As Mylan Storms The Market / A rollercoaster of a week for India’s Ranbaxy ends with yet another mystery – what is the status of its first-to-file applications for Pfizer’s Caduet? / PharmAsia News Dec. 2, 2011 3:00 PM GMT

Korea's National Health Insurance In Need Of Reimbursement Overhaul / Korea will consider ditching fee-for-service in favor of comprehensive reimbursement. NHI finally has a surplus, and internal recommendations call for a complete restructuring of reimbursement that can allow for increased insurance coverage. / PharmAsia News Dec. 1, 2011 3:35 PM GMT

China To Inspect Drug Ex-factory Prices: Good News Or Bad News? / China’s powerful National Development and Reform Commission To Launch Investigations On Pricing Disparities / PharmAsia News Dec. 1, 2011 2:59 PM GMT

Ranbaxy Bags Atorvastatin Approval From U.S. FDA In A Nail-Biting Finish / U.S. FDA grants approval for the Lipitor generic to Ranbaxy at the last moment, and Ranbaxy announces a surprise deal with Teva, but mystery remains over a final settlement with FDA. / PharmAsia News Dec. 1, 2011 2:30 PM GMT

India Case Study: Novartis’ Galvus Inches Closer To Merck’s Januvia As Battle For Brand Supremacy Rages On / Three years after Novartis and MSD launched their DPP-4 inhibitors in India, PharmAsia News takes a closer look at who will come out on top. / PharmAsia News Nov. 30, 2011 4:40 PM GMT

Convergence Of Clinical Trial Requirements Requires Flexibility Of Industry And Regulators – APEC Harmonization Workshop / Regional harmonization may not be necessary as long as there is regulatory cooperation, says U.S. FDA. / PharmAsia News Nov. 30, 2011 4:00 PM GMT

Turkey Import Policies Said Discouraging To Foreign Drug Makers / Turkey’s import pricing policies are causing at least one foreign drug maker to consider the viability of doing business there. / PharmAsia News Dec. 1, 2011 4:01 PM GMT

Israel’s Given Imaging Sues Korea’s Intromedic For Patent Infringement / Israel’s Given Imaging has sued South Korea’s Intromedic for alleged patent infringement involving a capsule endoscopy system that relies on miniature video cameras to film the small intestine. / PharmAsia News Dec. 1, 2011 3:58 PM GMT

Indian Scientist At U.S. Firm Admits Taking Trade Secrets For India Rival / An Indian scientist working for U.S. drug-supplier Frontier Scientific pleaded guilty to providing a brother-in-law in India with company secrets to be used in establishing a competitor. / PharmAsia News Dec. 1, 2011 3:55 PM GMT

Australia Accused Of Delay In Coverage Of Key Drugs For Budget Reasons / Australia’s Pharmaceutical Benefits Scheme plans more than 40 changes in drug coverage that Health Minister Nicola Roxon said would benefit more than 160,000 Aussie patients. / PharmAsia News Dec. 1, 2011 3:51 PM GMT

China National Health Insurance Eases Some Drug-Reimbursement Cuts / China’s health-insurance program to increase reimbursements for more than 80 branded drugs for treating chronic diseases. / PharmAsia News Dec. 1, 2011 3:46 PM GMT

China Study Says More Than Half Of Men Aged 60 And Over Have BPH / A Chinese study concludes that more than half of the nation’s men over 60 have benign prostatic hyperplasia, reflecting an expected surge in cases due to a rapidly aging population. / PharmAsia News Dec. 1, 2011 3:43 PM GMT

Vietnam Ponders Ban On Roche’s Avastin For Metastic Breast Cancer / Vietnam drug authorities said they are considering a ban on Roche’s Avastin (bevacizumab) for treating breast cancer in the wake of U.S. FDA’s similar action. / PharmAsia News Nov. 30, 2011 4:54 PM GMT

Indian Minister Frets 100% FDI In Pharmas Will Allow MNC Domination / An Indian Cabinet minister said he was concerned about a possible hike in drug prices in the country because multinational drug makers are allowed to buy 100% of local firms. / PharmAsia News Nov. 30, 2011 4:49 PM GMT

Japan’s ABsize Gets U.S. FDA Clearance For Phase I Pain-Patch Trials / Japanese biotech ABsize received clearance from U.S. FDA to conduct clinical trials of its AB001 anti-inflammatory transdermal patch for sprains and other acute pain. / PharmAsia News Nov. 30, 2011 4:35 PM GMT

China Vaccine Makers Plan To Go Global Despite Product-Safety Doubts / Chinese drug makers intend to enter the global market for vaccines in a major way, building on creation of the world’s first treatment for the 2009 version of the H1N1 influenza virus commonly known as “swine flu.” / PharmAsia News Nov. 30, 2011 5:00 AM GMT